(*) CA Approval Date: 2020. 02.12.
(*) EU Approval Date: 2015. 01.15.
(*) JP Approval Date: 2016. 12.20.
(*) USA Approval Date: 2014. 03.21.
>Treat.>Apremilast Tablets
Company
Oral PDE-4 Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2020. 04.07.
TradeMark
TradeMark Web-Site